FNY Investment Advisers’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,000
Closed -$61K 872
2019
Q4
$61K Buy
+10,000
New +$61K 0.02% 436